# The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND

> **NCT02993367** · PHASE2,PHASE3 · UNKNOWN · sponsor: **The Second Hospital of Hebei Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Vascular Cognitive Impairment no Dementia

## Interventions

- **DRUG:** Butylphthalide Soft Capsules
- **DRUG:** Placebo Butylphthalide Soft Capsules

## Key facts

- **NCT ID:** NCT02993367
- **Lead sponsor:** The Second Hospital of Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02993367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02993367, "The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02993367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*